四半期純利益、資産の部 - 薬業
- 【期間】
年度 | 四半期純利益 | 資産の部 - 薬業 |
---|
2010/06 | 24.2億 | | - | |
2010/09 | 42.4億 | +75% | - | |
2010/12 | 70.1億 | +65.2% | - | |
2011/03 | 82.1億 | +17.2% | - | |
2011/06 | 21.8億 | -73.5% | - | |
2011/09 | 46.1億 | +111.3% | - | |
2011/12 | 66.6億 | +44.5% | - | |
2012/03 | 82.8億 | +24.4% | - | |
2012/06 | 21億 | -74.6% | - | |
2012/09 | 46.2億 | +119.6% | - | |
2012/12 | 73.8億 | +59.9% | - | |
2013/03 | 89.9億 | +21.8% | 681億 | |
2013/06 | 22.1億 | -75.5% | - | |
2013/09 | 46億 | +108.3% | - | |
2013/12 | 74.3億 | +61.6% | - | |
2014/03 | 97.4億 | +31% | 647億 | -5% |
2014/06 | 26.3億 | -73% | - | |
2014/09 | 56.4億 | +114.4% | - | |
2014/12 | 96.1億 | +70.3% | - | |
2015/03 | 121億 | +26.2% | 709億 | +9.6% |
2015/06 | 63億 | -48% | - | |
2015/09 | 125億 | +98.1% | - | |
2015/12 | 201億 | +61.3% | - | |
2016/03 | 211億 | +5% | 752億 | +6.2% |
2016/06 | 58億 | -72.6% | - | |
2016/09 | 114億 | +97.5% | - | |
2016/12 | 180億 | +57.1% | - | |
2017/03 | 220億 | +22.4% | 769億 | +2.2% |
2017/06 | 54.6億 | -75.2% | - | |
2017/09 | 109億 | +98.9% | - | |
2017/12 | 169億 | +55.1% | - | |
2018/03 | 190億 | +13% | 854億 | +11.1% |
2018/06 | 40.4億 | -78.8% | - | |
2018/09 | 88.4億 | +119.1% | - | |
2018/12 | 142億 | +61.2% | - | |
2019/03 | 178億 | +24.8% | 819億 | -4.1% |
2019/06 | 48.3億 | -72.8% | - | |
2019/09 | 95.5億 | +97.8% | - | |
2019/12 | 156億 | +62.9% | - | |
2020/03 | 194億 | +24.5% | 696億 | -15% |
2020/06 | 38.2億 | -80.3% | - | |
2020/09 | 72.3億 | +89.2% | - | |
2020/12 | 109億 | +51.3% | - | |
2021/03 | 134億 | +22.6% | 717億 | +3% |
2021/06 | 33.6億 | -74.9% | - | |
2021/09 | 67.2億 | +99.9% | - | |
2021/12 | 102億 | +52.4% | - | |
2022/03 | 95.5億 | -6.8% | 756億 | +5.5% |
2022/06 | 29.1億 | -69.6% | - | |
2022/09 | 59.6億 | +105.2% | - | |
2022/12 | 91.5億 | +53.4% | - | |
2023/03 | 54.4億 | -40.5% | 742億 | -1.8% |
2023/06 | 25.1億 | -53.9% | - | |
2023/09 | 40.7億 | +62.1% | - | |
2023/12 | 66.8億 | +64.1% | - | |
2024/03 | 80.3億 | +20.2% | 860億 | +15.9% |
2024/06 | 17.5億 | -78.1% | - | |
2024/09 | 143億 | +714.5% | - | |